BCM
MRNA icon

Bridgeway Capital Management’s Moderna MRNA Stock Holding History

Bridgeway Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,100
Closed -$3.49M – 1351
2023
Q4 		$3.49M Sell
35,100
-17,800
-34% -$1.5M 0.07% 410
2023
Q3 		$5.46M Sell
52,900
-1,100
-2% -$123K 0.13% 258
2023
Q2 		$6.56M Buy
+54,000
New +$7.2M 0.16% 203
2022
Q3 		– Sell
-6,500
Closed -$929K – 1436
2022
Q2 		$929K Hold
6,500
– – 0.02% 741
2022
Q1 		$1.12M Hold
6,500
– – 0.02% 754
2021
Q4 		$1.65M Hold
6,500
– – 0.03% 676
2021
Q3 		$2.5M Buy
+6,500
New +$2.4M 0.05% 533

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgeway Capital Management's MRNA Position: Q1 2024 in Review

Bridgeway Capital Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 35,100 shares — an estimated $3.49M sold.

Bridgeway Capital Management first reported a position in MRNA in Q3 2021 and held it in 7 quarters. The position peaked at $6.56M in Q2 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Bridgeway Capital Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 35,100 Moderna shares in Q1 2024, an estimated $3.49M.
  • Bridgeway Capital Management first reported a position in Moderna in Q3 2021 and held it in 7 quarters.
  • Bridgeway Capital Management's Moderna position peaked at $6.56M in Q2 2023.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.